Product Information
PROCHLORPERAZINE 10 MG TAB is a generic product labeled by Amneal Pharmaceuticals NY LLC, priced at $0.1621 per EA under NDC 60219203901. Its NADAC has been published 165 times since Aug 9, 2023.
FDA first approved this application on Apr 17, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/1
Manufacturer
Amneal Pharmaceuticals NY LLCNDC
60219203901
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
PROCHLORPERAZINE MALEATEApproval Type
Generic (ANDA)
FDA Application
ANDA216598FDA Approved
4/17/2023
TE Code
AB
On Market Since
4/21/2023
Pharmacological Classes
Price Statistics
The NADAC for PROCHLORPERAZINE 10 MG TAB has been published 165 times since Aug 9, 2023, and over the history we have for it it has declined 63.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1621 per EA |
|---|---|
| All-time high | $0.4381 (Aug 16, 2023) |
| All-time low | $0.1493 (Nov 20, 2024) |
| 52-week high | $0.2036 |
| 52-week low | $0.1621 |
| Median price | $0.2036 |
| Average price | $0.2426 |
| Largest weekly change | -40.9% (Nov 20, 2024) |
| Weeks tracked | 165 |
| Tracking since | Aug 9, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the prochlorperazine maleate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Amneal Pharmaceuticals NY LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
prochlorperazine maleate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Phenothiazine class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PROCHLORPERAZINE 10 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for PROCHLORPERAZINE 10 MG TAB, manufactured by Amneal Pharmaceuticals NY LLC, is $0.1621 per EA (NDC 60219203901), effective Sep 30, 2026.
How has the price of PROCHLORPERAZINE 10 MG TAB changed over time?
Over the history we have for it, the NADAC for PROCHLORPERAZINE 10 MG TAB has declined 63.0%. It has been tracked across 165 weekly CMS publications since Aug 9, 2023.
What are the highest and lowest recorded NADAC prices for PROCHLORPERAZINE 10 MG TAB?
Since Aug 9, 2023, the NADAC for PROCHLORPERAZINE 10 MG TAB has ranged from a low of $0.1493 (Nov 20, 2024) to a high of $0.4381 (Aug 16, 2023), with a median of $0.2036 per EA.
Are there cheaper alternatives to PROCHLORPERAZINE 10 MG TAB?
No other NADAC-published product currently shares the active ingredient and strength of PROCHLORPERAZINE 10 MG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures PROCHLORPERAZINE 10 MG TAB?
PROCHLORPERAZINE 10 MG TAB (NDC 60219203901) is labeled by Amneal Pharmaceuticals NY LLC, and CMS classifies it as a generic product.